Executive Team

Led by industry veterans with a proven track record in biotech commercialization, bioinformatics, and AI innovation.

Justin Byers, Founder, CEO
A biopharma sales leader with 10+ years in life sciences, specializing in building biomanufacturing services from the ground up
Brian Staats, Co-founder, CTO
Technology leader specializing in bioinformatics with 20+ years of experience in modeling, data science, and engineering

Advisory Team

A powerhouse advisory team with deep expertise in biologics, R&D, and life sciences leadership—credited with 20+ approved drugs, major exits, and successful capital raises.

Graham Brearley, Ph.D.
A BioPharma expert with 30+ years of experience in biologics development, operations leadership, and business growth through acquisitions, divestitures, and due diligence
Greg Bleck, Ph.D.
Former VP of R&D at Catalent, co-founded Gala Design, developed technologies used in 20+ approved biopharmaceuticals, contributed to 175+ clinical trial molecules, and holds 20+ patents
Patrick Haffey
Life sciences executive with 20 years experience building, qualifying, and commercializing new biopharma manufacturing businesses in the US and abroad

Investment Opportunity

Axio BioPharma stands at the forefront of AI-driven biopharmaceutical manufacturing, addressing a rapidly growing market with innovative solutions. Our unique position offers investors a compelling opportunity to be part of a transformative journey in healthcare.

Invest with Us

Let's develop together!

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.